ClinicalTrials.gov record

Completed No phase listed Observational Accepts healthy volunteers Results available

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

ClinicalTrials.gov ID: NCT00862277

Public ClinicalTrials.gov record NCT00862277. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier

Study identification

NCT ID: NCT00862277
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Enrollment: 763 participants

Conditions and interventions

Conditions

Interventions

Menactra® Biological
Menomune® Biological

Biological

Eligibility (public fields only)

Age range: 14 Years to 27 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2008
Primary completion: Feb 28, 2009
Completion: Nov 30, 2009
Last update posted: Apr 13, 2016

2008 – 2009

United States locations

U.S. sites: 20
U.S. states: 9
U.S. cities: 18

Facility	City	State	ZIP	Site status
Not listed	Little Rock	Arkansas	72205	—
Not listed	Fountain Valley	California	92708	—
Not listed	Marietta	Georgia	30062	—
Not listed	Martinez	Georgia	30907	—
Not listed	Woodstock	Georgia	30189	—
Not listed	Bardstown	Kentucky	40004	—
Not listed	Omaha	Nebraska	68131	—
Not listed	Austintown	Ohio	44515	—
Not listed	Cleveland	Ohio	44121	—
Not listed	Erie	Pennsylvania	16505	—
Not listed	Greenville	Pennsylvania	16125	—
Not listed	Harleysville	Pennsylvania	19438	—
Not listed	Latrobe	Pennsylvania	15650	—
Not listed	Pittsburgh	Pennsylvania	15236	—
Not listed	Pittsburgh	Pennsylvania	15241	—
Not listed	Sellersville	Pennsylvania	18960	—
Not listed	Wexford	Pennsylvania	15090	—
Not listed	Kingsport	Tennessee	37660	—
Not listed	Spokane	Washington	99202	—
Not listed	Spokane	Washington	99218	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00862277, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 13, 2016 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00862277 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →